Transfusion reaction: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(12 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}; {{AE}} [https://www.wikidoc.org/index.php/User:K.Nouman <nowiki>Khuram Nouman, M.D. [2]</nowiki>]  {{ADS}}
{{CMG}} {{shyam}}; {{AE}} [https://www.wikidoc.org/index.php/User:K.Nouman <nowiki>Khuram Nouman, M.D. [2]</nowiki>]  {{ADS}}


==Overview==
==Overview==
Blood products, when transfused even after cross matching, elicit some reactions. The transfusion reactions are classified into [[anaphylactic]] reaction, bacterial infection, acute hemolytic reaction, febrile non-hemolytic reaction, [[transfusion related acute lung injury|transfusion-related acute lung injury]][[TRALI]], [[transfusion-associated circulatory overload]], transfusion-associated microchimerism (TA-MC), iron overload, and transfusion-associated [[Graft-versus-host disease|Graft-versus-Host Disease]] (GvHD). The symptoms may range from fever to life threatening [[anaphylaxis]]. The treatment of each different type of transfusion reaction is different.


==Types of Transfusion Reactions==
==Types of Transfusion Reactions==


===Febrile Non-hemolytic Transfusion Reaction===
===Anaphylactic Reaction===
*This is the most common adverse reaction to a blood transfusion.
*An [[anaphylaxis|anaphylactic]] (or severe [[Allergy|allergic]]) reaction can occur at a rate of 1 per 30,000-50,000 [[Blood transfusion|transfusions]].  
*Symptoms include [[fever]] and [[dyspnea]] 1 to 6 hours after receiving the transfusion.  
*These reactions are most common in people with [[selective IgA deficiency]] (although IgA deficiency is often [[asymptomatic]], and people may not know they have it until an anaphylactic reaction occurs).  
*Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. [[Bacteria]]l infection is a much more common problem.
===Bacterial Infection===
===Bacterial Infection===
*Blood products can provide an excellent medium for [[bacteria]]l growth, and can become contaminated after collection while they are being stored.  
*Blood products can provide an excellent medium for [[bacteria]]l growth, and can become contaminated after collection while they are being stored.  
Line 20: Line 20:
*The symptoms are [[fever]] and chills, sometimes with [[back pain]] and pink or red urine ([[hemoglobinuria]]).  
*The symptoms are [[fever]] and chills, sometimes with [[back pain]] and pink or red urine ([[hemoglobinuria]]).  
*The major complication is that [[hemoglobin]] released by the destruction of red blood cells can cause [[acute renal failure]].
*The major complication is that [[hemoglobin]] released by the destruction of red blood cells can cause [[acute renal failure]].
===Anaphylactic Reaction===
===Febrile Non-hemolytic Transfusion Reaction===
*An [[anaphylaxis|anaphylactic]] (or severe allergic) reaction can occur at a rate of 1 per 30,000-50,000 transfusions.  
*This is the most common adverse reaction to a blood transfusion.
*These reactions are most common in people with [[selective IgA deficiency]] (although IgA deficiency is often [[asymptomatic]], and people may not know they have it until an anaphylactic reaction occurs).  
*Symptoms include [[fever]] and [[dyspnea]] 1 to 6 hours after receiving the transfusion.
===Transfusion-associated Acute Lung Injury (TRALI)===
*Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. [[Bacteria]]l infection is a much more common problem.
===Transfusion-Related Acute Lung Injury (TRALI)===
*[[TRALI]] is a syndrome of acute [[respiratory distress]], often associated with [[fever]], non-cardiogenic [[pulmonary edema]], and [[hypotension]].  
*[[TRALI]] is a syndrome of acute [[respiratory distress]], often associated with [[fever]], non-cardiogenic [[pulmonary edema]], and [[hypotension]].  
*It may occur as often as 1 in 2000 transfusions.  
*It may occur as often as 1 in 2000 transfusions.  
*Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.
*Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.
===Volume Overload===
*Patients with impaired cardiac function (eg [[congestive heart failure]]) can become volume-overloaded as a result of blood transfusion, leading to [[edema]], [[dyspnea]] (shortness of breath), and [[orthopnea]] (shortness of breath while lying flat).  *This is sometimes called TACO, or Transfusion Associated Circulatory Overload.
===Iron overload===
*Each transfused unit of [[red blood cell]]s contains approximately 250 mg of elemental [[iron]].
*Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop [[iron overload]], which can in turn damage the [[liver]], [[heart]], [[kidney]]s, and [[pancreas]]. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.
===Transfusion-associated Graft-vs-Host Disease (GvHD)===
*[[graft-versus-host disease|GVHD]] refers to an immune attack by transfused cells against the recipient. This is a common complication of [[stem cell transplant]]ation, but an exceedingly rare complication of blood transfusion. It occurs only in severely immunosuppressed patients, primarily those with [[congenital]] immune deficiencies or [[hematological malignancy|hematologic malignancies]] who are receiving intensive [[chemotherapy]]. When GVHD occurs in association with blood transfusion, it is almost uniformly fatal. Transfusion-associated GVHD can be prevented by [[irradiation|irradiating]] the blood products prior to transfusion.
===Transfusion-associated Microchimerism (TA-MC)===
===Transfusion-associated Microchimerism (TA-MC)===
*Transfusion-associated [[Chimera (genetics)#Microchimerism|microchimerism]] is the stable persistence of donor's genetically distinct cells (usually <5%) in a recipient's circulation following fresh [[blood transfusion]], especially in the setting of [[Physical trauma|trauma]].  
*Transfusion-associated [[Chimera (genetics)#Microchimerism|microchimerism]] is the stable persistence of donor's genetically distinct cells (usually <5%) in a recipient's circulation following fresh [[blood transfusion]], especially in the setting of [[Physical trauma|trauma]].  
*As a result of the current advancement in [[polymerase chain reaction]] techniques, TA-MC has been demonstrated among patients with [[Physical trauma|trauma]] following [[blood transfusion]], [[pregnancy]] and [[transplant|organ or stem cell transplantation]].  Several studies have implicated other forms of [[Chimera (genetics)#Microchimerism|microchimerism]], including [[Chimera (genetics)|fetomaternal microchimerism]], with acute and chronic illnesses such as [[congenital heart block]] in a patient with [[neonatal lupus erythematosus]] and [[systemic sclerosis]].
*As a result of the current advancement in [[polymerase chain reaction]] techniques, TA-MC has been demonstrated among patients with [[Physical trauma|trauma]] following [[blood transfusion]], [[pregnancy]] and [[transplant|organ or stem cell transplantation]].  Several studies have implicated other forms of [[Chimera (genetics)#Microchimerism|microchimerism]], including [[Chimera (genetics)|fetomaternal microchimerism]], with acute and chronic illnesses such as [[congenital heart block]] in a patient with [[neonatal lupus erythematosus]] and [[systemic sclerosis]].
*Genetic factors such as the [[Tumor necrosis factors|TNF]] (-308A) [[single nucleotide polymorphism]]s (SNP) have been implicated in the development of TA-MC.  The risk of developing TA-MC is largely dependent on the clinical setting, i.e., it is rare in situations which do not involve massive trauma.  Although [[leukoreduction]] removes > 99.9% of donor's [[white blood cell]]s, it has not been proven to prevent the development of TA-MC.
===Transfusion-associated Graft-vs-Host Disease (GvHD)===
*[[graft-versus-host disease|GVHD]] refers to an immune attack by transfused cells against the recipient. This is a common complication of [[stem cell transplant]]ation, but an exceedingly rare complication of blood transfusion.
*It occurs only in severely immunosuppressed patients, primarily those with [[congenital]] immune deficiencies or [[hematological malignancy|hematologic malignancies]] who are receiving intensive [[chemotherapy]].
*When GVHD occurs in association with blood transfusion, it is almost uniformly fatal. Transfusion-associated GVHD can be prevented by [[irradiation|irradiating]] the blood products prior to transfusion.
===Volume Overload===
*Patients with impaired cardiac function (e.g. [[congestive heart failure]]) can become volume-overloaded as a result of blood transfusion, leading to [[edema]], [[dyspnea]] (shortness of breath), and [[orthopnea]] (shortness of breath while lying flat).
*This is sometimes called TACO, or Transfusion Associated Circulatory Overload.<ref>Suddock JT, Crookston KP. Transfusion Reactions. [Updated 2018 Sep 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482202/</ref>


Genetic factors such as the [[Tumor necrosis factors|TNF]] (-308A) [[single nucleotide polymorphism]]s (SNP) have been implicated in the development of TA-MC. The risk of developing TA-MC is largely dependent on the clinical setting, i.e., it is rare in situations which do not involve massive trauma.  Although [[leukoreduction]] removes > 99.9% of donor's [[white blood cell]]s, it has not been proven to prevent the development of TA-MC.
===Iron Overload===
*Each transfused unit of [[red blood cell]]s contains approximately 250 mg of elemental [[iron]].
*Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop [[iron overload]], which can in turn damage the [[liver]], [[heart]], [[kidney]]s, and [[pancreas]]. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.
Following table summarizes the difference between transfusion-related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO):
{|
! style="background:#4479BA; color: #FFFFFF;" align="center" |Parameters
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion-related acute lung injury (TRALI)
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion-associated circulatory overload (TACO)
|-
! align="center" style="background:#DCDCDC;" |[[Fever]]
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |−
|-
! align="center" style="background:#DCDCDC;" |[[Blood pressure]]
| align="center" style="background:#F5F5F5;" | [[Hypotension]]
| align="center" style="background:#F5F5F5;" | [[Hypertension]]
|-
! align="center" style="background:#DCDCDC;" |[[Respiratory failure|Respiratory distress]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
|-
! align="center" style="background:#DCDCDC;" |[[Jugular venous pressure|JVP]]
| align="center" style="background:#F5F5F5;" | Non-distended
| align="center" style="background:#F5F5F5;" | Distended
|-
! align="center" style="background:#DCDCDC;" |[[Auscultation|Respiratory auscultation]]
| align="center" style="background:#F5F5F5;" | [[Rales]]
| align="center" style="background:#F5F5F5;" | [[Rales]] + [[Heart sounds|S3]] heart sounds may be present
|-
! align="center" style="background:#DCDCDC;" |[[Chest X-ray|CXR]]
| align="center" style="background:#F5F5F5;" | Bilateral [[Lung|pulmonary]] infiltrates
| align="center" style="background:#F5F5F5;" | Bilateral [[Lung|pulmonary]] infiltrates
|-
! align="center" style="background:#DCDCDC;" |[[Fluid balance]]
| align="center" style="background:#F5F5F5;" | Neutral
| align="center" style="background:#F5F5F5;" | Positive
|-
! align="center" style="background:#DCDCDC;" |[[Diuretic|Diuretics]]
| align="center" style="background:#F5F5F5;" | Responsive only when there is fluid overload
| align="center" style="background:#F5F5F5;" | Improvement with [[Diuretic|diuretics]]
|-
! align="center" style="background:#DCDCDC;" |[[Ejection fraction]]
| align="center" style="background:#F5F5F5;" | Normal
| align="center" style="background:#F5F5F5;" | Decreased
|-
! align="center" style="background:#DCDCDC;" |[[Brain natriuretic peptide|BNP]]
| align="center" style="background:#F5F5F5;" | <250 pg/mL
| align="center" style="background:#F5F5F5;" | >1200 pg/mL
|-
! align="center" style="background:#DCDCDC;" |[[Pulmonary capillary wedge pressure|PCWP]]
| align="center" style="background:#F5F5F5;" | <18 mm Hg
| align="center" style="background:#F5F5F5;" | >18 mm Hg
|-
! align="center" style="background:#DCDCDC;" |[[White blood cells|WBC]]
| align="center" style="background:#F5F5F5;" | Unchanged
| align="center" style="background:#F5F5F5;" | Transient decreased
|}


==Treatment of Transfusion Reactions==
==Treatment of Transfusion Reactions==
The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient. More specific treatments depend on the nature and presumed cause of the transfusion reaction. Most [[hospital]]s and medical centers have transfusion reaction [[Guideline (medical)|protocols]], which specify testing of the blood product and patient for [[hemolysis]], bacterial contamination, etc.
* The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient.
 
* More specific treatments depend on the nature and presumed cause of the transfusion reaction.  
The following table shows different types of transfusion reactions along with their treatment,
* Most [[hospital]]s and medical centers have transfusion reaction [[Guideline (medical)|protocols]], which specify testing of the blood product and patient for [[hemolysis]], bacterial contamination, etc.
The following table shows different types of transfusion reactions along with their treatment:
{|
{|
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion  Reaction  
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion  Reaction  
Line 65: Line 124:
| align="center" style="background:#F5F5F5;" |−
| align="center" style="background:#F5F5F5;" |−
| align="left" style="background:#F5F5F5;" |  
| align="left" style="background:#F5F5F5;" |  
* Hypotension
* [[Hypotension]]
| align="left" style="background:#F5F5F5;" |  
| align="left" style="background:#F5F5F5;" |  
* Wheezing
* [[Wheeze|Wheezing]]
* stridor
* [[Stridor]]
* cyanosis
* [[Cyanosis]]
* soft tissue edema
* Soft tissue [[edema]]
| align="left" style="background:#F5F5F5;" |  
| align="left" style="background:#F5F5F5;" |  
* CBC
* [[Complete blood count|CBC]]
* spO2 monitoring
* [[Arterial blood gas|ABG]]
* type and screen
* Type and screen
| align="left" style="background:#F5F5F5;" |  
| align="left" style="background:#F5F5F5;" |  
* Stop the transfusion immediately
* Stop the transfusion immediately
Line 81: Line 140:
| align="left" style="background:#F5F5F5;" |  
| align="left" style="background:#F5F5F5;" |  
* Avoid clerical errors
* Avoid clerical errors
* proper storage record
* Proper storage record
* repeat type and screen before transfusion
* Repeat type and screen before transfusion
* proper blood storage conditions
* Proper blood storage conditions
| align="center" style="background:#F5F5F5;" | [[IgA deficiency]]
| align="center" style="background:#F5F5F5;" | [[IgA deficiency]]
|-
|-
Line 94: Line 153:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Hypotension is common
* Hypotension is common
* occasionally hypertension
* Occasionally hypertension
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* fever > 2
* Fever > 2
* tachycardia
* Tachycardia
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* CBC
* CBC
* Urine complete examination
* Urine complete examination
* blood and urine culture
* Blood and urine culture
* transfusion set culture
* Transfusion set culture
* clotting profile
* Clotting profile
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Stop the transfusion
* Stop the transfusion
* Check identity on blood unit
* Check identity on blood unit
* look for clerical errors
* Look for clerical errors
* Supportive management(O2 inhalation,normal saline)
* Supportive management(O2 inhalation,normal saline)
* broad spectrum antibiotics for bacterial infections
* Broad spectrum antibiotics for bacterial infections
* inform blood bank
* Inform blood bank
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Extensive screening of blood  
* Extensive screening of blood  
* decrease storage time
* Decrease storage time
* leukodepletion
* Leukodepletion
* bactericidal treatment  
* Bactericidal treatment  
| align="center" style="background:#F5F5F5;" |±
| align="center" style="background:#F5F5F5;" |±
|-
|-
Line 128: Line 187:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Chest pain
* Chest pain
* apprehension
* Apprehension
* flank pain
* Flank pain
* dark urine([[Hemoglobinura]])
* Dark urine([[Hemoglobinura]])
* [[Renal failure]]
* [[Renal failure]]
* oozing from venipuncture site  ( DIC)  
* Oozing from venipuncture site  ( DIC)  
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* CBC
* CBC
Line 144: Line 203:
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Stop the transfusion immediately
* Stop the transfusion immediately
* look for clerical errors
* Look for clerical errors
* alert blood bank
* Alert blood bank
* maintain IV access  
* Maintain IV access  
* supportive management  
* Supportive management  
* to prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis
* To prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis
* Treat DIC(if happens)
* Treat DIC(if happens)
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* Avoid clerical errors
* Avoid clerical errors
* proper storage record
* Proper storage record
* repeat type and screen before transfusion
* Repeat type and screen before transfusion
* proper blood storage conditions
* Proper blood storage conditions
| align="center" style="background:#F5F5F5;" |[[ABO incompatibility (patient information)|ABO incompatibility]]
| align="center" style="background:#F5F5F5;" |[[ABO incompatibility (patient information)|ABO incompatibility]]
|-
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion  Reaction
! style="background:#4479BA; color: #FFFFFF;" align="center" |Time of onset
! style="background:#4479BA; color: #FFFFFF;" align="center" |Fever
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rigors
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rash
! style="background:#4479BA; color: #FFFFFF;" align="center" |Blood Pressure
! style="background:#4479BA; color: #FFFFFF;" align="center" |Additional Features
! style="background:#4479BA; color: #FFFFFF;" align="center" |Labs
! style="background:#4479BA; color: #FFFFFF;" align="center" |Treatment
! style="background:#4479BA; color: #FFFFFF;" align="center" |Prevention
! style="background:#4479BA; color: #FFFFFF;" align="center" |Mechanism/
Examples
|-
|-
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Febrile non-hemolytic transfusion reaction
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Febrile non-hemolytic transfusion reaction
Line 166: Line 238:
* No Effect
* No Effect
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* can occur in first few hours
* Can occur in first few hours
* fever rise of 1-2  
* Fever rise of 1-2  
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* No labs usually required
* No labs usually required
Line 185: Line 257:
* Hypotension
* Hypotension
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* cough
* Cough
* pink frothy sputum
* Pink frothy sputum
* [[Respiratory distress]]
* [[Respiratory distress]]
* [[Pulmonary edema]]
* [[Pulmonary edema]]
Line 192: Line 264:
* ABGs
* ABGs
* CBC
* CBC
* spO2 monitoring
* SpO2 monitoring
* CXR-pulmonary infiltrates
* CXR-pulmonary infiltrates
* HLA typing(remove donor from the list)
* HLA typing(remove donor from the list)
Line 198: Line 270:
* Stop the transfusion immediately
* Stop the transfusion immediately
* O2 inhalation
* O2 inhalation
* ventilatory support
* Ventilatory support
* supportive treatment
* Supportive treatment
* Diuretics for volume overload
* Diuretics for volume overload
* inform the blood bank
* Inform the blood bank
* consult hematologist
* Consult hematologist
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* donor whose blood cause TRALI must be put on non-donor list
* Donor whose blood cause TRALI must be put on non-donor list
| align="center" style="background:#F5F5F5;" | Donor anti-leukocyte antibodies
| align="center" style="background:#F5F5F5;" | Donor anti-leukocyte antibodies
|-
|-
Line 215: Line 287:
* Hypertension
* Hypertension
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* dyspnea
* Dyspnea
* orthopnea
* Orthopnea
* cough
* Cough
* headache
* Headache
* tachycardia
* Tachycardia
* decrease spO2
* Decrease spO2
* increase JVP
* Increase JVP
* increase CVP
* Increase CVP
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* spO2 monitoring
* SpO2 monitoring
* CXR
* CXR
* serum BNP
* Serum BNP
* ABGs
* ABGs
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
Line 232: Line 304:
* Supportive therapy
* Supportive therapy
* O2 supplementation
* O2 supplementation
* ventilatory support
* Ventilatory support
* diuretics
* Diuretics
* exchange transfusion(if transfusion is unavoidable)
* Exchange transfusion(if transfusion is unavoidable)
* controlled phelbotomy
* Controlled phelbotomy
| align="left" style="background:#F5F5F5;" |
| align="left" style="background:#F5F5F5;" |
* slow rate of transfusion
* Slow rate of transfusion
* avoid unnecessary transfusion
* Avoid unnecessary transfusion
* cardiac evluation
* Cardiac evaluation
| align="center" style="background:#F5F5F5;" | +++
| align="center" style="background:#F5F5F5;" | +++
|}
|}
Transfusion-related acute lung injury (TRALI) can be differentiated from Transfusion associated circulatory overload (TACO) as followed,
{|
! style="background:#4479BA; color: #FFFFFF;" align="center" |Parameters
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion-related acute lung injury (TRALI)
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion-associated circulatory overload (TACO)
|-
! align="center" style="background:#DCDCDC;" |Fever
| +/-
| -
|-
! align="center" style="background:#DCDCDC;" |Blood pressure
|hypotension
|hypertension
|-
! align="center" style="background:#DCDCDC;" |Respiratory Distress
| +
| +
|-
! align="center" style="background:#DCDCDC;" |JVP
|non-distended
|distended
|-
! align="center" style="background:#DCDCDC;" |Respiratory auscultation
|Rales
|Rales + S3 heart sounds may be present
|-
! align="center" style="background:#DCDCDC;" |CXR
|bilateral pulmonary infiltrates
|bilateral pulmonary infiltrates
|-
! align="center" style="background:#DCDCDC;" |Fluid balance
|neutral
|positive
|-
! align="center" style="background:#DCDCDC;" |Diuretics
|responsive only when there is fluid overload
|Improvement with diuretics
|-
! align="center" style="background:#DCDCDC;" |Ejection fraction
|normal
|decrease
|-
! align="center" style="background:#DCDCDC;" |BNP
|<250 pg/mL
|>1200 pg/mL
|-
! align="center" style="background:#DCDCDC;" |PCWP
|<18 mm Hg
|>18 mm Hg
|-
! align="center" style="background:#DCDCDC;" |WBC
|unchanged
|transient decrease
|}
==See also==
*[[Blood transfusion]]
==External links==
*[[ICD-10 Chapter T]]: [http://www3.who.int/icd/currentversion/fr-icd.htm?gt80.htm+t80 World Health Organisation classification] -  Complications following infusion, transfusion and therapeutic injection


== References ==
== References ==
{{reflist|2}}
<div class="references-small">
<div class="references-small">
<references /></div>
<references /></div>


[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 00:42, 31 December 2018

WikiDoc Resources for Transfusion reaction

Articles

Most recent articles on Transfusion reaction

Most cited articles on Transfusion reaction

Review articles on Transfusion reaction

Articles on Transfusion reaction in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Transfusion reaction

Images of Transfusion reaction

Photos of Transfusion reaction

Podcasts & MP3s on Transfusion reaction

Videos on Transfusion reaction

Evidence Based Medicine

Cochrane Collaboration on Transfusion reaction

Bandolier on Transfusion reaction

TRIP on Transfusion reaction

Clinical Trials

Ongoing Trials on Transfusion reaction at Clinical Trials.gov

Trial results on Transfusion reaction

Clinical Trials on Transfusion reaction at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Transfusion reaction

NICE Guidance on Transfusion reaction

NHS PRODIGY Guidance

FDA on Transfusion reaction

CDC on Transfusion reaction

Books

Books on Transfusion reaction

News

Transfusion reaction in the news

Be alerted to news on Transfusion reaction

News trends on Transfusion reaction

Commentary

Blogs on Transfusion reaction

Definitions

Definitions of Transfusion reaction

Patient Resources / Community

Patient resources on Transfusion reaction

Discussion groups on Transfusion reaction

Patient Handouts on Transfusion reaction

Directions to Hospitals Treating Transfusion reaction

Risk calculators and risk factors for Transfusion reaction

Healthcare Provider Resources

Symptoms of Transfusion reaction

Causes & Risk Factors for Transfusion reaction

Diagnostic studies for Transfusion reaction

Treatment of Transfusion reaction

Continuing Medical Education (CME)

CME Programs on Transfusion reaction

International

Transfusion reaction en Espanol

Transfusion reaction en Francais

Business

Transfusion reaction in the Marketplace

Patents on Transfusion reaction

Experimental / Informatics

List of terms related to Transfusion reaction

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Khuram Nouman, M.D. [2] Amandeep Singh M.D.[3]

Overview

Blood products, when transfused even after cross matching, elicit some reactions. The transfusion reactions are classified into anaphylactic reaction, bacterial infection, acute hemolytic reaction, febrile non-hemolytic reaction, transfusion-related acute lung injuryTRALI, transfusion-associated circulatory overload, transfusion-associated microchimerism (TA-MC), iron overload, and transfusion-associated Graft-versus-Host Disease (GvHD). The symptoms may range from fever to life threatening anaphylaxis. The treatment of each different type of transfusion reaction is different.

Types of Transfusion Reactions

Anaphylactic Reaction

Bacterial Infection

  • Blood products can provide an excellent medium for bacterial growth, and can become contaminated after collection while they are being stored.
  • The risk is highest with platelet transfusion, since platelets must be stored near room temperature and cannot be refrigerated.
  • The risk of severe bacterial infection and sepsis is estimated (as of 2001) at about 1 in 50,000 platelet transfusions, and 1 in 500,000 red blood cell transfusions.

Acute Hemolytic Reaction

Febrile Non-hemolytic Transfusion Reaction

  • This is the most common adverse reaction to a blood transfusion.
  • Symptoms include fever and dyspnea 1 to 6 hours after receiving the transfusion.
  • Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. Bacterial infection is a much more common problem.

Transfusion-Related Acute Lung Injury (TRALI)

  • TRALI is a syndrome of acute respiratory distress, often associated with fever, non-cardiogenic pulmonary edema, and hypotension.
  • It may occur as often as 1 in 2000 transfusions.
  • Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.

Transfusion-associated Microchimerism (TA-MC)

Transfusion-associated Graft-vs-Host Disease (GvHD)

  • GVHD refers to an immune attack by transfused cells against the recipient. This is a common complication of stem cell transplantation, but an exceedingly rare complication of blood transfusion.
  • It occurs only in severely immunosuppressed patients, primarily those with congenital immune deficiencies or hematologic malignancies who are receiving intensive chemotherapy.
  • When GVHD occurs in association with blood transfusion, it is almost uniformly fatal. Transfusion-associated GVHD can be prevented by irradiating the blood products prior to transfusion.

Volume Overload

  • Patients with impaired cardiac function (e.g. congestive heart failure) can become volume-overloaded as a result of blood transfusion, leading to edema, dyspnea (shortness of breath), and orthopnea (shortness of breath while lying flat).
  • This is sometimes called TACO, or Transfusion Associated Circulatory Overload.[1]

Iron Overload

  • Each transfused unit of red blood cells contains approximately 250 mg of elemental iron.
  • Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop iron overload, which can in turn damage the liver, heart, kidneys, and pancreas. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.

Following table summarizes the difference between transfusion-related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO):

Parameters Transfusion-related acute lung injury (TRALI) Transfusion-associated circulatory overload (TACO)
Fever ±
Blood pressure Hypotension Hypertension
Respiratory distress + +
JVP Non-distended Distended
Respiratory auscultation Rales Rales + S3 heart sounds may be present
CXR Bilateral pulmonary infiltrates Bilateral pulmonary infiltrates
Fluid balance Neutral Positive
Diuretics Responsive only when there is fluid overload Improvement with diuretics
Ejection fraction Normal Decreased
BNP <250 pg/mL >1200 pg/mL
PCWP <18 mm Hg >18 mm Hg
WBC Unchanged Transient decreased

Treatment of Transfusion Reactions

  • The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient.
  • More specific treatments depend on the nature and presumed cause of the transfusion reaction.
  • Most hospitals and medical centers have transfusion reaction protocols, which specify testing of the blood product and patient for hemolysis, bacterial contamination, etc.

The following table shows different types of transfusion reactions along with their treatment:

Transfusion Reaction Time of onset Fever Rigors Rash Blood Pressure Additional Features Labs Treatment Prevention Mechanism/

Examples

Anaphylactic reaction
  • Rapid onset
  • Stop the transfusion immediately
  • S/C epinephrine
  • IV epinephrine(in case of severe hypotension)
  • Avoid clerical errors
  • Proper storage record
  • Repeat type and screen before transfusion
  • Proper blood storage conditions
IgA deficiency
Bacterial Infection
  • Rapid onset
++ + ±
  • Hypotension is common
  • Occasionally hypertension
  • Fever > 2
  • Tachycardia
  • CBC
  • Urine complete examination
  • Blood and urine culture
  • Transfusion set culture
  • Clotting profile
  • Stop the transfusion
  • Check identity on blood unit
  • Look for clerical errors
  • Supportive management(O2 inhalation,normal saline)
  • Broad spectrum antibiotics for bacterial infections
  • Inform blood bank
  • Extensive screening of blood
  • Decrease storage time
  • Leukodepletion
  • Bactericidal treatment
±
Acute hemolytic reaction
  • Rapid onet
+ + ±
  • Hypotension
  • Stop the transfusion immediately
  • Look for clerical errors
  • Alert blood bank
  • Maintain IV access
  • Supportive management
  • To prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis
  • Treat DIC(if happens)
  • Avoid clerical errors
  • Proper storage record
  • Repeat type and screen before transfusion
  • Proper blood storage conditions
ABO incompatibility
Transfusion Reaction Time of onset Fever Rigors Rash Blood Pressure Additional Features Labs Treatment Prevention Mechanism/

Examples

Febrile non-hemolytic transfusion reaction
  • 1/2 to 1 hour
+, with chills +
  • No Effect
  • Can occur in first few hours
  • Fever rise of 1-2
  • No labs usually required
  • Slow or Stop the transfusion
  • Give Acetaminophen for fever
  • Leukoreduction
Cytokine in storage
Transfusion-related acute lung injury (TRALI) within 6 hours ± ±
  • Hypotension
  • ABGs
  • CBC
  • SpO2 monitoring
  • CXR-pulmonary infiltrates
  • HLA typing(remove donor from the list)
  • Stop the transfusion immediately
  • O2 inhalation
  • Ventilatory support
  • Supportive treatment
  • Diuretics for volume overload
  • Inform the blood bank
  • Consult hematologist
  • Donor whose blood cause TRALI must be put on non-donor list
Donor anti-leukocyte antibodies
Transfusion-associated circulatory overload (TACO) usually over hours
  • Hypertension
  • Dyspnea
  • Orthopnea
  • Cough
  • Headache
  • Tachycardia
  • Decrease spO2
  • Increase JVP
  • Increase CVP
  • SpO2 monitoring
  • CXR
  • Serum BNP
  • ABGs
  • Stop transfusion
  • Supportive therapy
  • O2 supplementation
  • Ventilatory support
  • Diuretics
  • Exchange transfusion(if transfusion is unavoidable)
  • Controlled phelbotomy
  • Slow rate of transfusion
  • Avoid unnecessary transfusion
  • Cardiac evaluation
+++

References

  1. Suddock JT, Crookston KP. Transfusion Reactions. [Updated 2018 Sep 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482202/